Builds relationships, and differentiates Novo Nordisk products in the marketplace, with targeted accounts that influence patient access and care around obesity care management. Targets include a range of influential stakeholders and decision makers, including but not limited to: Employers; Payers/Regional Pharmacy Benefit managers (PBMs), Health Systems with aligned Payers and Health systems as employer, Municipalities and Employer Coalitions, as defined by the role. Account activities include, but are not limited to, market development of obesity as a disease driving need for Anti-obesity management as "standard listing"; formulary placement/consideration for Novo Nordisk products, integrating overall Novo Nordisk Inc (NNI) brand and corporate awareness across the customer 's organizational structure. Eco-system engagement of key stakeholders to align around obesity management, treatment/protocols that will accelerate growth in local markets.
This position reports into a Director or Senior Director within the Area Market Access Team.
Internally, this position has the responsibility of informing all appropriate NNI personnel of any access changes or updates in account status within targeted accounts, which may impact sales and marketing activities or other efforts across the organization. Key collaboration partners include the entire Market Access & Public Affairs Team, PCOR (Pricing, Contracting, Operations and Reimbursement), Marketing, Area Commercial Sales Team, Medical Affairs, Legal & Compliance and Human Resources.
External relationships include responsibility for multiple channels and customers as outlined in The Position of this Job Description. This role also develops productive relationships and maintains contact with key account personnel, including C-suite executives and department heads. Additionally, this role maintains relationships with other local associations, organizations, and patient support partners.
50-75% overnight travel required; Driver must maintain a valid driver’s license. Must be in good standing by not exceeding the Novo Nordisk points threshold assigned based on review of Motor Vehicle Records.
We are world leaders in diabetes care with a growing business in other treatment areas like hemophilia. We are approximately 42,000 employees in 77 countries. Join us!